| Unbound MEDLINE results for: | Bookmark this site | | Articles related to 18591385 [Unique ID], provided by the PubMed system | |
| |
|
| | 1 - 10 of 102 journal articles in the PubMed database | Email to a friend | | |
| Paoluzzi L, Gonen M, Bhagat G, et al.
The BH3-only mimetic ABT-737 synergizes the anti-neoplastic activity of proteasome inhibitors in lymphoid malignancies. [JOURNAL ARTICLE]
Blood 2008 Jun 30.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Paoluzzi L, Gonen M, Gardner JR, et al.
Targeting Bcl-2 family members with the BH3 mimetic AT-101 markedly enhances the therapeutic effects of chemotherapeutic agents in in vitro and in vivo models of B-cell lymphoma. [JOURNAL ARTICLE]
Blood 2008 Feb 21.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Perez-Galan P, Roue G, Villamor N, et al.
The BH3-mimetic GX15-070 synergizes with Bortezomib in Mantle Cell Lymphoma by enhancing Noxa-mediated activation of Bak. [JOURNAL ARTICLE]
Blood 2007 Jan 16.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Plosker GL, Figgitt DP
Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia. [Clinical Trial, Journal Article, Randomized Controlled Trial, Review]
Drugs 2003; 63(8):803-43.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Kang MH, Kang YH, Szymanska B, et al.
Activity of vincristine, L-ASP, and dexamethasone against acute lymphoblastic leukemia is enhanced by the BH3-mimetic ABT-737 in vitro and in vivo. [JOURNAL ARTICLE]
Blood 2007 May 29.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Pérez-Galán P, Roué G, López-Guerra M, et al.
BCL-2 phosphorylation modulates sensitivity to the BH3 mimetic GX15-070 (Obatoclax) and reduces its synergistic interaction with bortezomib in chronic lymphocytic leukemia cells. [JOURNAL ARTICLE]
Leukemia 2008 Jul 3.
Abstract | Full Citation | | Kang MH, Wan Z, Kang YH, et al.
Mechanism of synergy of N-(4-hydroxyphenyl)retinamide and ABT-737 in acute lymphoblastic leukemia cell lines: Mcl-1 inactivation. [Journal Article, Research Support, Non-U.S. Gov't]
J Natl Cancer Inst 2008 Apr 16; 100(8):580-95.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Tse C, Shoemaker AR, Adickes J, et al.
ABT-263: a potent and orally bioavailable Bcl-2 family inhibitor. [Journal Article]
Cancer Res 2008 May 1; 68(9):3421-8.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Mohammad RM, Goustin AS, Aboukameel A, et al.
Preclinical Studies of TW-37, a New Nonpeptidic Small-Molecule Inhibitor of Bcl-2, in Diffuse Large Cell Lymphoma Xenograft Model Reveal Drug Action on Both Bcl-2 and Mcl-1. [JOURNAL ARTICLE]
Clin Cancer Res 2007 Apr 1; 13(7):2226-2235.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |   |
|
| | Enter
www.unboundmedicine.com/medline
in your iPhone browser
or View our
Unbound MEDLINE
iPhone demo
Advertise on this site.
|
